Owner Variagenics, Inc. a Delaware corporation

Service Davies Collison Cave

Various Convention priority claimed: 21 August 2001, United States of America, No 76/302684 in respect of goods in class 5.* Convention priority claimed: 21 August 2001, United States of America, No 76/302683 in respect of goods in class 42.*

Class 5 Diagnostic preparations used to identify in a patient a genetic variation affecting drug action; pharmaceutical preparations for the treatment of cancer, proliferative diseases, inflammatory diseases, or cardiovascular diseases whose effect is related to the said genetic variation

Class 42 Development of pharmaceutical preparations (including scientific research for medical purposes) whose mechanism of action is related to genetic variation in the management and treatment of diseases, disorders or dysfunctions

Class 44 Providing medical information relating to the identification of genetic variations affecting safety, toxicity and efficacy of drug therapy and the development of companion molecule diagnostic products for the identification of these variations in patients with known diseases, disorders or dysfunctions